Literature DB >> 23020533

Late-onset multiple sclerosis in Isfahan, Iran.

Masoud Etemadifar1, Seyed-Hossein Abtahi, Alireza Minagar, Mojtaba Akbari, Ali Masaeli, Nasim Tabrizi.   

Abstract

BACKGROUND: Multiple sclerosis (MS) typically affects young adults; however, the first symptoms can occur after age 50 and is classified as late-onset MS (LOMS).
METHODS: In this retrospective study, we extracted the records of 3522 MS patients (2716 females and 806 males) registered in the Isfahan MS Society (IMSS) from 2003 to 2010. Next, we searched for LOMS cases. We aimed to compare these cases with 1698 non-LOMS subjects also extracted from the IMSS database.
RESULTS: We found 48 LOMS patients (28 females and 20 males), which gave a crude frequency of 1.36%. The frequency by sex of LOMS in males (2.4%) was significantly greater than in females (1.0%, P = 0.002). The mean age at onset was 55.1 ± 4.3 years. The female to male ratio of 1.4:1 in these patients was significantly lower than in non-LOMS subjects (3.37:1, P = 0.003). The leading pattern of MS was relapsing-remitting (RR) in 62.5%, followed by primary progressive (PP) in 27.1%, and secondary progressive (SP) in 10.4%. Predominant presenting symptoms and signs were motor disturbances (35.4%), followed by brainstem (25%), optic neuritis (22.9%), and sensory related deficits (18.7%). The mean progression index (PI) in LOMS patients (0.88 ± 0.48) was significantly higher than in non-LOMS cases, 0.37 ± 0.17 (P < 0.0001). DISCUSSION: In comparing LOMS patients with the non-LOMS cohort, there was a higher frequency of the PP pattern and a higher PI in the LOMS group. In comparing other high-risk populations with the Isfahan cohort, LOMS formed a lower percentage of the total Isfahan MS population.

Entities:  

Mesh:

Year:  2012        PMID: 23020533     DOI: 0121510/AIM.004

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  4 in total

1.  Clinical-radiological-pathological spectrum of central nervous system-idiopathic inflammatory demyelinating disease in the elderly.

Authors:  W Oliver Tobin; Chiara Costanzi; Yong Guo; Joseph E Parisi; Stephen D Weigand; Claudia F Lucchinetti
Journal:  Mult Scler       Date:  2016-10-19       Impact factor: 6.312

2.  Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.

Authors:  Afsaneh Shirani; Yinshan Zhao; John Petkau; Paul Gustafson; Mohammad Ehsanul Karim; Charity Evans; Elaine Kingwell; Mia L van der Kop; Joel Oger; Helen Tremlett
Journal:  Biomed Res Int       Date:  2015-04-01       Impact factor: 3.411

3.  Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?

Authors:  Raed Alroughani; Saeed Akhtar; Samar Ahmed; Raed Behbehani; Jasem Al-Hashel
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

4.  Psychosocial and Medical Determinants of Health-related Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis.

Authors:  Isaac Rahimian Boogar; Siavash Talepasand; Mohammad Jabari
Journal:  Noro Psikiyatr Ars       Date:  2018-03-19       Impact factor: 1.339

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.